NCT04879888 - Personalized Vaccine for Cancer Immunotherapy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 30, 2016

Study Completion Date

July 30, 2017

Conditions

Breast Cancer Female

Interventions

BIOLOGICAL

Peptide pulsed Dendritic cell

Intradermal vaccination with peptide-pulsed autologous dendritic cells in 200 µL of patient's serum in six doses weekly after surgery.

Trial Locations (1)

Facultad de Medicina - Universidad Nacional de Colombia, Bogota

All Listed Sponsors

collaborator

Fundación Salud de los Andes

OTHER

collaborator

Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología (COLCIENCIAS)

OTHER_GOV

collaborator

Subred Integrada de Servicios de Salud Sur ESE - Colombia (South America)

UNKNOWN

lead

Universidad Nacional de Colombia

OTHER